Trials / Withdrawn
WithdrawnNCT04685551
Improving Survivorship Among Minority Cancer Dyads
Improving Survivorship Outcomes for African American and Latinx Cancer Survivors and Caregiver Dyads Through A Culturally Based Training Program for Underserved Health Professional Students
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Charles Drew University of Medicine and Science · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This proposed intervention centers on improving survivorship outcomes among African American and Latinx cancer survivor and caregiver dyads. As a result, there will be four major outcomes. First, as a result of partnership with minority social institutions (e.g. faith leaders), we will develop an in-depth culturally sensitive curriculum and survivorship care plan for Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs). Second, we will increase knowledge and skills by evaluating a comprehensive cancer survivorship training program designed for underserved health professional students. Third, the implementation of this program will improve survivorship outcomes among African American and Latinx cancer survivors with advanced stage cancer and their caregivers. Lastly, this study will build sustainability for underserved minorities with the training of 30 future healthcare providers as a valuable community resource for improving cancer survivorship outcomes. The long-term outcomes of the CSC LAMPs program will generate workforce capacity and diversity in cancer-based clinical practice, research, and community advocacy for underserved minority cancer survivors and caregivers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Change in knowledge, motivation, skills, and resources | Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to improve survivorship outcomes. |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2024-06-30
- Completion
- 2024-12-31
- First posted
- 2020-12-28
- Last updated
- 2022-07-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04685551. Inclusion in this directory is not an endorsement.